Abstract
There is an interesting divergence between the achievements of geriatrics and gerontology. On the one hand, during the last 30 years physicians in many developed countries have successfully prescribed several medicines to cure various symptoms of senescence. On the other hand, the influence of such medicines on human life span practically has not been studied. The most common of the relevant medicines are nootropic piracetam, gamma-aminobutyric acid (GABA), selegiline, Ginkgo biloba, pentoxifylline, cerebrolysin, solcoseryl, ergoloid, vinpocetin, sertraline, and estrogens, among others. Available data from human clinical practices and experimental animal studies indicate that treatments with these drugs improve learning, memory, brain metabolism, and capacity. Some of these drugs increase tolerance to various stresses such as oxygen deficit and exercise, stimulate the regeneration of neurons in the old brain, and speed up the performance of mental and physical tasks. This means that modern medicine already has "antiaging" treatments at its disposal. However, the influence of such treatments on the mean and maximal life span of humans, and on the age trajectory of a human survival curve has been poorly studied. The increase in h...Continue Reading
References
Aug 1, 1976·Acta Psychiatrica Scandinavica·P MindusD Schalling
Jan 1, 1991·Archives of Internal Medicine·B E HendersonR K Ross
Jan 1, 1991·Current Medical Research and Opinion·G S RaiK A Wesnes
Jan 1, 1990·Life Sciences·N W MilgramG O Ivy
Jan 1, 1986·Current Medical Research and Opinion·F HuberR Spiegel
Jul 1, 1995·Pharmacopsychiatry·H V SemlitschK A Decker
Jan 1, 1996·Obstetrics and Gynecology·B EttingerC P Quesenberry
Aug 1, 1996·The American Journal of Clinical Nutrition·K G LosonczyR J Havlik
Mar 1, 1997·Neurobiology of Aging·S Brailowsky, T Montiel
Jan 1, 1997·Life Sciences·W W RuehlF F Hahn
Mar 13, 1998·JAMA : the Journal of the American Medical Association·K YaffeD Grady
Aug 11, 1998·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·H al-ZuhairM I el-Sayed
May 25, 1999·Pharmacopsychiatry·K ScheuerW E Müller
Oct 9, 1999·The American Journal of Pathology·G S AshcroftM W Ferguson
Mar 23, 2001·JAMA : the Journal of the American Medical Association·E S LeBlancH D Nelson
May 10, 2001·Proceedings of the National Academy of Sciences of the United States of America·K G Manton, X Gu
Jan 5, 2002·Neurobiology of Aging·B TopicJ P Huston
Mar 14, 2002·Journal of the American Geriatrics Society·H Agüero-TorresJ Louhija
Mar 7, 2003·Alzheimer Disease and Associated Disorders·Michael C Sha, Christopher M Callahan
Apr 26, 2003·Neurobiology of Aging·C JonkerJ H Smit
May 6, 2003·Science·Audie G LeventhalYuanye Ma
Citations
Feb 23, 2005·The Analyst·Changqing LiuXing-Fang Li
Feb 5, 2008·Rejuvenation Research·Alexander M KulminskiAnatoli I Yashin
Jul 23, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Xu-Juan LiDe-Qiang Li
Jan 17, 2012·Acta Odontologica Scandinavica·Ufuk SezerFahrettin Göze
Nov 25, 2017·Restorative Neurology and Neuroscience·Mikhail StepanichevNatalia Gulyaeva
Apr 8, 2006·Stroke; a Journal of Cerebral Circulation·Svetlana UkraintsevaAnatoly Yashin
May 14, 2010·Anais Brasileiros De Dermatologia·Milton Luiz Gorzoni, Sueli Luciano Pires
Oct 20, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·G R Tabeeva